We’re pleased to announce that Thomas Hughes, JD has joined RCRI in the role of Health Economics and Reimbursement Sr. Principal Advisor. Hughes is senior level executive and attorney with nearly 20 years of experience in the medical technology industry and 7 years practicing healthcare law with a major Minneapolis law firm representing physicians, hospitals, and other providers. In his years in the medical technology and legal arenas, Hughes helped advise and provide leadership for start-up and national companies by using a keen eye for strategic planning blended with the unique expertise in developing and executing reimbursement strategies and payer relations initiatives with payers, provider groups, government agencies, and other key decision makers.
In his position, Hughes will be expanding RCRI’s strategic consulting and operational services as well as maintaining relationships. “I see RCRI as a strong, preferred partner to medical technology companies,” stated Hughes. “RCRI provides deep expertise to create customized, innovative partnerships that, in addition to providing end-point services, also truly engage medical technology companies to identify and implement their strategic and business growth needs. These services will be well received by growing medical technology organizations.”
“Health economics and reimbursement is one of the most critical emerging issues in the device space today. Tom’s expertise and problem solving approach in this area will be of tremendous help to our clients in creating novel and effective strategies. We are extremely impressed with his accomplishments and his leadership qualities and are thrilled to appoint him to this position.” stated Lisa Olson, the company’s President.
Hughes holds a BA in Political Science from the University of Minnesota and a JD from the William Mitchell College of Law and is a member in good standing with the Minnesota State Bar Association. He continues active engagement as a member of the Executive Council Member of Health Law Committee and the FDA Regulatory Committee. He is also active in both the Medical Industry Leadership Institute at the University of Minnesota’s Carlson School of Management and the Neurostimulation Device Alliance.